risedronate sodium

Generic: risedronate sodium

Labeler: hangzhou minsheng binjiang pharmaceutical co., ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name risedronate sodium
Generic Name risedronate sodium
Labeler hangzhou minsheng binjiang pharmaceutical co., ltd
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

risedronate sodium hemi-pentahydrate 35 mg/1

Manufacturer
Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd

Identifiers & Regulatory

Product NDC 60723-041
Product ID 60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207516
Listing Expiration 2026-12-31
Marketing Start 2019-04-01

Pharmacologic Class

Classes
bisphosphonate [epc] diphosphonates [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60723041
Hyphenated Format 60723-041

Supplemental Identifiers

RxCUI
905024 905092 905100
UNII
HU2YAQ274O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name risedronate sodium (source: ndc)
Generic Name risedronate sodium (source: ndc)
Application Number ANDA207516 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 35 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)
  • 3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)
source: ndc

Packages (2)

60723-041-04 1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) 60723-041-12 3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)

Ingredients (1)

risedronate sodium hemi-pentahydrate (35 mg/1)

Linked Drug Pages (1)

Risedronate Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "460cdef1-681b-7ae4-e063-6294a90a1d55", "openfda": {"unii": ["HU2YAQ274O"], "rxcui": ["905024", "905092", "905100"], "spl_set_id": ["d60a56cb-ef49-4447-9043-7b6879a20d75"], "manufacturer_name": ["Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (60723-041-04)  / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)", "package_ndc": "60723-041-04", "marketing_start_date": "20190401"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (60723-041-12)  / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)", "package_ndc": "60723-041-12", "marketing_start_date": "20190401"}], "brand_name": "Risedronate Sodium", "product_id": "60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "60723-041", "generic_name": "Risedronate Sodium", "labeler_name": "Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Risedronate Sodium", "active_ingredients": [{"name": "RISEDRONATE SODIUM HEMI-PENTAHYDRATE", "strength": "35 mg/1"}], "application_number": "ANDA207516", "marketing_category": "ANDA", "marketing_start_date": "20190401", "listing_expiration_date": "20261231"}